Publications

View a complete Pubmed search

 

View a complete Google Scholar search

 

 

  1. Barron, A.M., Tokunaga, M., Zhang, M., Bin J., Suhara, T., Higuchi, M. Assessment of neuroinflammation in a mouse model of obesity and β-amyloidosis using PET. Journal of Neuroinflammation. 13:221. (2016).
  2. Porcu, P., Barron, A.M., Frye, C., Yang, S-Y., Melcangi, R., Panzica, G. Neurosteroidogenesis today: Novel targets for neurosteroid synthesis and action and their relevance for translational research. Journal of Neuroendocrinology. 28(2). (2016).
  3. Verdile, G.V., Asih, P. Barron, A.M., Whajoepramono, E.J., Ittner, L.M., Martins, R.N. The Impact of Luteinizing hormone and Testosterone on beta amyloid (Aβ) accumulation: animal and human clinical studies. Hormones and Behavior. 76: 81-90. (2015).
  4. Munetomo, A., Hojo, Y., Higo, S., Kato, A., Yoshida, K., Shirasawa, T., Shimizu, T., Barron, A.M., Kimoto, T., Kawato, S. Aging-induced changes in sex-steroidogenic enzymes and sex-steroid receptors in cortex, hypothalamus and brain. Journal of Physiological Sciences. 65(3): 253-63. (2015).
  5. Barron, A.M., Brown, M.A., Lin, S.A., Morgan, T., Pike, C.J. Impact of cyclic versus constant progesterone regimens on estrogen neuroprotection in rat entorhinal cortex. Endocrinology. 156(3):1091-9. (2015).
  6. Asih, P.R., Bin, J., Katsifis, A., Mattner, F., Caruso, D., Melcangi, R.C., Higuchi, M., Martins, R.N., Barron, A.M. In vivo evaluation of the therapeutic potential of novel translocator protein (TSPO) ligands for the treatment of Alzheimer’s disease. Alzheimer`s & Dementia. 11 (7): P156. (2015). Abstract.
  7. Higuchi, M., Bin, J., Maeda, J., Barron, A.M., Suhara, T. Imaging inflammation in Alzheimer`s disease. Dementia Japan. 28(2):211-219. (In Japanese). (2014).
  8. Asih, P.R., Barron, A.M., Bin, J., Katsifis, A., Mattner, F., Verdile, G., Gupta, V., Trengrove, R., Martins, R.N. Novel translocator protein (TSPO) ligands for the potential treatment of Alzheimer’s disease: A next generation alternative to conventional hormone therapy. Alzheimer`s & Dementia. 10 (4): P860. (2014). Abstract.
  9. Barron, A.M., Tokunaga, M., Ji, B., Suhara, T., Higuchi, M. PET imaging of synergistic, but modally distinct obesity- and Aβ-triggered abnormalities in cerebral glucose metabolism and gliosis in mice. Alzheimer`s & Dementia. 10(4): P268. (2014). Abstract.
  10. Barron, A.M., Christensen, A. Ji, B., Suhara, T., Higuchi, M., Pike, C.J. The role of steroid biosynthesis in the protective actions of ligands for the translocator protein (TSPO). Alzheimer`s & Dementia. 10(4): P779. (2014). Abstract.
  11. Barron, A.M., Rosario, E.R., Eltereifi, R., Pike, C.J. Sex-specific effects of a high fat diet on indicies of metabolic syndrome in 3xTgAD mice: Implications for Alzheimer’s disease. PLOS One. 28:8 (10)* e78554. (2013).
  12. Barron, A.M., Garcia-Segura, L.M., Caruso, D., Jayaraman, A.,Won Lee, J., Melcangi, R.C., Pike, C.J. Ligand for translocator protein reverses pathology in a mouse model of Alzheimer’s disease. Journal of Neuroscience. 33(20): 8891-8897. (2013).
  13. Brown, M.A., Jones, C.L., Sampson, E.L., Barron, A.M. Prognostic indicators of six-month mortality in elderly people with advanced dementia: A systematic review of the literature. Palliative Medicine. 27(5): 389-399. (2013).
  14. Caruso, D.*, Barron, A.M.*, Brown, M.A., Abbiati F., Carrero, P., Pike, C.J., Garcia-Segura, L-M., Melcangi, R.C. Age-related changes in neuroactive steroid levels in 3xTg-AD mice. Neurobiology of Aging. 34(4):1080-9. (2013).*Both authors contributed equally.
  15. Barron, A.M., Jayaraman, A., Lee, J.-W., Hojo, Y., Higuchi, M., Pike, C., Kawato, S. Ligand for translocator protein increases hippocampal expression of glial Aβ scavenger receptors and reduces Aβ in male mice & rats. Alzheimer`s and Dementia. 9(4): P703. (2013).
  16. Aras, R., Barron, A.M., Pike, C.J. Caspases contribute to astrogliosis. Brain Research. 1450:102-115. (2012).
  17. Barron, A.M., Pike C.J. Sex hormones, aging, and Alzheimer’s disease. Frontiers in Bioscience. E4, 976-997. (2012).
  18. Barron, A.M., Garcia-Segura, L.-M., Caruso, D., Melcangi, R., Pike, C. Ligand for translocator protein reverses pathology in a mouse model of Alzheimer’s disease. Alzheimer`s & Dementia. 8(4): P260-P261. (2012).
  19. Barron, A.M., Hojo Y., Mukai H., Higo S., Ooishi Y., Hatanaka Y., Ogiue-Ikeda M., Murakami G., Kimoto T., Kawato S. Regulation of synaptic plasticity by hippocampus synthesised estradiol. Hormone Molecular Biology and Clinical Investigations. 7 (2): 361-375. (2011)
  20. Higo S., Hojo Y., Ishii H., Komatsuzaki Y., Ooishi Y., Murakami G., Mukai H., Yamazaki T., Nakahara D., Barron, A.M., Kimoto T., Kawato S. Endogenous Synthesis of Corticosteroids in the Hippocampus. PLoS ONE. 6:e21631. (2011).
  21. Barron, A.M., Verdile G., Taddei K., Bates K.A., Martins R.N. Effect of chronic hCG administration on Alzheimer’s-related cognition and Abeta accumulation in PS1KI mice. Endocrinology. 151:5380-5388. (2010).
  22. Barron, A.M. Rosario, E.R., Brown, M.A. Pike, C. Sex-specific effects of a high fat diet on indices of metabolic syndrome in 3xTgAD mice: Implications for Alzheimer`s disease. Alzheimer`s and Dementia. 6(4): e22. (2010).
  23. Pike C.J., Carroll J.C., Rosario E.R., Barron, A.M. Protective actions of sex steroid hormones in Alzheimer’s disease. Frontiers in Neuroendocrinology. 30 (2): 106-118. (2009).
  24. Barron, A.M., Cake, M., Verdile, G., Martins, R.N. Ovariectomy and 17β-estradiol replacement do not alter beta amyloid levels in sheep brain. Endocrinology. 150: 3228-3236. (2009).
  25. Rosario, E.R., Carroll, J. C., Brown, M.A., Barron, A.M. Pike, C.J. Dietary induction of type 2 diabetes increases Alzheimer-like pathology in male 3xTg-AD mice. Alzheimer`s & Dementia. 5(4): P441. (2009). Abstract.
  26. Powers-Martin, K.*, Barron, A.M.*, McKitrick, D.J., Arnolda, L.F., Phillips, J.K. Immunohistochemical assessment of cyclic guanosine monophosphate (cGMP) and soluble guanylate cyclase (sGC) within the rostral ventrolateral medulla. Journal of Biomedical Science. 15(6):801-812. (2008). * Both authors contributed equally.
  27. Barron, A.M., Taddei, K., Verdile, G. and Martins, R.N. Time and dose dependent effects of human chorionic gonadotropin on APP processing and beta amyloid levels in the PS1M146V mouse model of Alzheimer’s disease. Alzheimer`s & Dementia. 4(4): T347. (2008). Abstract.
  28. Barron, A.M., Verdile G., Martins R.N. The Role of Luteinizing Hormone in Alzheimer’s Disease. In Gonadal and Nongonadal Actions of Gonadotropins. Delhi, India: Narosa Publishing House Pvt. Ltd; pp 275-90. (2008).
  29. Barron, A.M., Taddei, K., Verdile, G., Martins, R.N. Human Chrorionic gonadotropin increases exploratory behaviour and impairs episodic-like memory in PS1M146V mice. Neuroscience Research. 58: S62. (2007). Abstract.
  30. Barron, A.M., Verdile, G., Martins, R.N. The role of gonadotropins in Alzheimer’s disease. Endocrine. 29 (2): 257-269. (2006).
  31. Barron, A.M., Fuller, S.J., Verdile, G., Martins, R.N. Reproductive hormones modulate oxidative stress in Alzheimer’s disease. Antioxidants and Redox Signaling. 8(11-12): 2047-2059. (2006).
  32. Barron, A.M. Verdile, G., Martins, R.N. Gonadotropins: potential targets for preventive and therapeutic interventions in Alzheimer’s disease. Future Neurology. 1(2): 191-204. (2006).
  33. Dixon, D.N., Loxley, R.A., Barron, A., Cleary, S. & Phillips, J.K. Comparative Studies of PC12 and MPC Pheochromocytoma Derived Rodent Cell Lines as Models for the Study of Neuroendocrine Systems. In Vitro Cellular & Developmental Biology. 41: 197-206. (2005).